Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ripasudil After Descemetorhexis in Fuchs Endothelial Corneal Dystrophy
NCT03575130Phase 2Unknown
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ripasudil in Fuchs endothelial corneal dystrophy (FECD), sponsored by FAU Erlangen-Nürnberg Medical Faculty. Status: unknown.
02
Drugs
ripasudil
03
Conditions
Fuchs endothelial corneal dystrophy (FECD)
Beyond the preview
Go deeper on NCT03575130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03575130.